Microwave-assisted SPPS: From discovery to commercial production

First published: January 18, 2022

In collaboration with our Microwave-Peptide Synthesis partner, CEM, AmbioPharm is pleased to introduce our new publication in the January-February 2022 issue of Specialty Chemicals Magazine. “Microwave-assisted SPPS: From discovery to commercial production” covers the advantages of microwave technology in solid phase peptide synthesis (SPPS), including time, energy, and solvent efficiencies.  With GMP capabilities at AmbioPharm in North Augusta, South Carolina, this technology is suitable for peptides in the entire product lifecycle from early discovery to commercial production. Another advantage of Microwave SPPS is obtaining a higher purity crude product, and a case study on the synthesis of liraglutide using the technology is also presented.

We invite you to read the article here: https://joom.ag/UBFI/p44

Learn more about our partnership with CEM here.

Read our latest case study: Rapid Process Development of Peptide Production via Microwave-Enhanced SPPS: A Case Study